Amicus Therapeutics Inc. buy BiotechBee
Start price
13.01.23
/
50%
€11.78
Target price
31.05.24
€17.00
Performance (%)
-9.18%
End price
05.05.23
€10.70
Summary
This prediction ended on 05.05.23 with a price of €10.70. With a performance of -9.18%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Amicus Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.395% | -0.696% | 15.472% |
iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% |
iShares Nikkei 225® | 1.617% | 2.769% | 11.442% |
iShares S&P 500 | 0.659% | 4.280% | 26.778% |
According to BiotechBee what are the pros and cons of Amicus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Buy mit Kursziel 17,0
In the thread Trading Amicus Therapeutics Inc.
Buy beendet